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Everglades virus (EVEV), an alphavirus in the
Venezuelan equine encephalitis complex, circulates among
rodents and vector mosquitoes in Florida and occasionally
infects humans. It causes febrile disease, sometimes
accompanied by neurologic manifestations. Although previ-
ous surveys showed high seroprevalence in humans, EVEV
infections may be underdiagnosed because the disease is
not severe enough to warrant a clinic visit or the undifferen-
tiated presentations complicate diagnosis. Documented
EVEV activity, as recent as 1993, was limited to south
Florida. Using dogs as sentinels, a serosurvey was
conducted to evaluate whether EVEV circulated recently in
Florida and whether EVEV’s spatial distribution parallels
that of the mosquito vector, Culex cedecei. Four percent of
dog sera contained neutralizing EVEV antibodies, and many
seropositive animals lived farther north than both recorded
EVEV activity and the principal vector. These results indi-
cate that EVEV is widespread in Florida and may be an
important, unrecognized cause of human illness.
E
verglades virus (EVEV), a mosquitoborne Venezuelan
equine encephalitis (VEE) complex alphavirus
(Togaviridae;  Alphavirus), circulates continuously in
enzootic foci in Florida. EVEV infection of humans can
result in a nonspecific, flulike, febrile illness that can
progress to severe neurologic disease (1,2). Human EVEV
serosurveys in the 1960s and 1970s indicated that people
in south Florida were frequently exposed to EVEV. In 1
survey (3), >50% of Seminole Indians who resided north
of Everglades National Park had antibody to EVEV, and
9% of other groups living in 3 rural communities at the
periphery of the park were EVEV seropositive in 1973 (4).
Despite high antibody prevalence, most seropositive
persons reported no history of symptoms or signs consis-
tent with VEE-like disease, although exceptions have been
noted (1,2). Among the small number of seropositive per-
sons who experienced illnesses consistent with EVEV
infection, the most common signs and symptoms were
fever, myalgia, headache, tender lymph nodes, and diar-
rhea (4). Although serologic data indicate that persons are
frequently exposed to EVEV, disease is probably most
often asymptomatic or not sufficiently severe to require a
visit to a physician. In addition, if an EVEV-infected per-
son seeks medical attention, the nonspecific clinical signs
and symptoms, similar to those caused by other viral dis-
eases, may not warrant etiologic diagnosis. Persons with
undiagnosed diseases of suspected viral etiology are not
routinely tested for EVEV by the Florida Department of
Health (L.M. Stark, pers. comm.). However, repeated evi-
dence of EVEV antibody in persons living at different
locales in south Florida (3,4) suggests that EVEV may be
an unrecognized cause of febrile illness.
All recorded EVEV activity has been limited to south
Florida, from Everglades National Park north to Indian
River County (5) (Figure 1). The last EVEV isolation was
reported in 1993 (6). As is the case with surveillance for
many arboviruses, EVEV activity may be noted only in
regions where virologists actively search. No recent sero-
surveys to detect current EVEV transmission have been
performed, and the geographic distribution of EVEV cir-
culation has never been defined by comprehensive sur-
veys. Laboratory susceptibility experiments suggest that
Culex (Melanoconion) cedecei may be the only important
EVEV vector (7,8). This species has only been reported in
12 southern counties of Florida (9), which indicates that if
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activity is probably limited to those areas. Therefore, the
goal of this study was to answer 3 questions: 1) Has EVEV
recently been circulating in Florida? 2) What is the geo-
graphic distribution of EVEV throughout the state? and 3)
Does the spatial distribution of EVEV activity, as meas-
ured by seroprevalence, parallel the recorded distribution
of the principal vector, Cx. cedecei?
Testing human sera for EVEV antibody would be an
ideal measure of human exposure, but obtaining these
samples is difficult from a logistic and regulatory stand-
point. Some human pathogen studies have used antibody
prevalence of domestic animals to predict human disease
risk (10–12). Canines are effective EVEV sentinels;
hemagglutination-inhibiting (HI) and neutralizing antibod-
ies without clinical disease developed in military sentry
dogs stationed outdoors in Homestead, Florida (13). Dogs
experimentally infected with VEEV (strains not reported)
survived infection, and minimal HI titers of 320 developed
(14). Furthermore, beagles exposed to Aedes triseriatus
mosquitoes infected with the VEEV subtype IAB Trinidad
Donkey strain became viremic from days 1 to 5 postinoc-
ulation, with virus titers ranging from 1 to 3.8 log10 mouse
intraperitoneal median lethal doses per milliliter
(MIPLD50) (15). In a reciprocal study, experimentally
infected beagles with viremias of at least 3.7 log10
MIPLD50 of VEEV were capable of infecting Ae. trise-
riatus mosquitoes (16). Taken together, these results
demonstrate that dogs become infected with EVEV or
VEEV by artificial and natural inoculation routes; produce
viremias of 3–4 days’ duration; sustain a nonfatal, febrile
infection; and develop detectable antibody.
Field studies in VEEV-enzootic foci outside Florida
also indicate that dogs are frequently infected during out-
breaks. Domestic dogs tested after epidemics in Colombia
(17), Venezuela (18), and Guatemala (19) commonly had
neutralizing antibody to VEEV. In these dogs, the average
neutralizing antibody titer was lower than titers in experi-
mentally infected canines, possibly reflecting a longer
window of time between exposure to VEEV and the time
of blood collection, a period during which antibody levels
could wane.
Because pet dogs live in close proximity to humans and
can serve as effective EVEV sentinels, human exposure to
EVEV can be estimated on the basis of dog seropreva-
lence. Pet dogs are also good sentinels for human
arbovirus risk because they more closely approximate the
biomass of a human than a hamster or another small mam-
mal, they are restricted to confined geographic zones such
as a backyard or neighborhood, and dog owners are knowl-
edgeable about the travel history of their pets. Therefore,
we evaluated the distribution of EVEV in Florida by using
pet dogs as sentinels of EVEV activity.
Materials and Methods
Serum Collection
Whole blood was collected from pet dogs seen for treat-
ment of various conditions at the University of Florida
Veterinary Medical Center in Gainesville, Florida, USA,
from July 2003 to January 2004, and at Hollywood Animal
Hospital in Hollywood (Miami), Florida, from June to
December 2004. Samples from animals living far from
Florida, in areas not known to be enzootic for VEEV com-
plex alphaviruses (Galveston, Texas, USA, and Munich,
Germany) were kindly provided by resident veterinarians
at local clinics and used as negative controls. Dogs from
all locations were randomly sampled independent of the
reason for the clinic visit. Serum was separated from ery-
throcytes after low-speed centrifugation. For dogs seen in
Gainesville, each pet owner was asked whether the animal
had traveled outside of their city of residence, except for
the visit to the veterinary clinic.
Antibody Assays
Each serum sample was tested by standard 80% plaque
reduction neutralization test (PRNT) (20). In brief, neutral-
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Figure 1. Everglades virus–seropositive and -seronegative dogs in
Florida, 2003–2004. A total of 633 samples of dog sera from the
Veterinary Medical Center in Gainesville or Hollywood Animal
Hospital in Miami were screened. Each blue dot (seronegative) or
red star (seropositive) represents a single dog. Most of the
seropositive dogs lived in north-central Florida, outside the record-
ed range of the principal vector Culex (Melanoconion) cedecei or
previously recorded Everglades virus activity (purple shading).
Owners of dogs living outside the endemic region reported that
their animal had not traveled to south Florida.izing antibody titers were determined by a constant-virus,
serum dilution procedure that used Vero (African green
monkey kidney) cell monolayers attached to 6- or 12-well
plates. Serum samples were heated at 56°C for 30 min for
inactivation, and a 1:10 starting serum dilution was serial-
ly 2-fold diluted and incubated with an equal volume (250
µL) of ≈800 PFU/mL of EVEV strain FE3–7c for 1 h at
37°C. The virus-serum mixture was incubated onto conflu-
ent Vero cell monolayers, overlaid after 1 h with 0.4% agar
in Eagle’s minimal essential medium and incubated at
37°C for 2 days. The virus was inactivated with 10%
formaldehyde, and cell monolayers were stained with
0.05% crystal violet in 30% methanol to visualize plaques.
Dilutions of serum that caused a >80% reduction in the
number of plaques, as compared with negative controls
(commercial fetal bovine serum and serum from dogs liv-
ing outside alphavirus-enzootic areas [Texas and
Germany]), were considered positive. Serum from an
experimentally infected, EVEV-immune cotton rat was
included as a positive control. The reciprocal of the high-
est dilution of serum (indicated as the final virus-serum
dilution) that inhibited at least 80% of plaques was record-
ed as the antibody titer. To rule out infection with Eastern
equine encephalitis virus (EEEV) and Highlands J viruses
(HJV), related alphaviruses also enzootic to Florida, all
EVEV-seropositive sera were screened by PRNT for anti-
body to these viruses by using the North American EEEV
strain FL-93 (21) and HJV strain 86–31227 (22).
Location Mapping
To delineate the geographic distribution of antibody to
EVEV in canines, the home location of each dog was
mapped with ArcGIS for ArcView 9.1 (ESRI, Redlands,
CA, USA). Owner street addresses were geocoded (Tele
Atlas, Lebanon, NH, USA) and overlaid with land cover
and water features (e.g., lakes, ponds, reservoirs, streams,
wetlands) from the National Land Cover Dataset (United
States Geological Survey, EROS Data Center, Sioux Falls,
SD, USA). The proximity of each dog residence relative to
water features and forest, agricultural, or suburban or
urban land was calculated. The landcover type at the resi-
dence location was also determined.
Results
Serology
A total of 633 serum samples from dogs living in
Florida were tested for EVEV antibody by PRNT. Of
these, 422 were from the Gainesville clinic, and 211 were
from the Miami clinic. At least 1 serum sample was
obtained from 54 of the 67 counties in Florida, and >20
samples per county were tested from 6 counties, including
the greater Miami-Dade area (Broward n = 152, Miami-
Dade n = 55, and Palm Beach n = 27) and Ocala region
(Marion n = 63). Although the greatest number of samples
came from the Miami area, the relative number of dog sera
collected per human population by county was highest for
Marion County (1 dog per 4,330 people), compared with
ratios of 1:45,392 and 1:12,544 in Miami-Dade and
Broward Counties, respectively.
Of the 633 sera tested, 26 (4%) contained antibody to
EVEV, with 80% PRNT endpoint titers ranging from 20 to
2,560 (Table). None of the EVEV PRNT-positive sera con-
tained detectable neutralizing antibody against EEEV or
HJV, which ruled out the possibility of cross-reactions
with related, sympatric alphaviruses. None of the dogs
from Texas or Germany had detectable antibody to EVEV.
The proportion of 80% PRNT-seropositive dogs from
Florida (26/633) was significantly greater than that for
dogs from Texas and Germany (0/61),which indicated that
serosurvey results from Florida dogs were not false posi-
tives (χ2 = 2.6, degrees of freedom [df] = 1, p<0.05).
Most of the EVEV-seropositive dogs had PRNT end-
point titers in the low range (20–40). Although the 80%
EVEV PRNT titer for 38% of the 26 seropositive dogs was
only 20, this value is considered protective for humans
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comparable to levels observed in dogs after outbreaks in
Venezuela (18). The youngest EVEV antibody–seropositive
dog was born in 2003, indicating that EVEV has been
circulating recently in the Miami-Dade area.
Geographic EVEV Distribution
A map of the geographic distribution of antibody to
EVEV in canines in Florida showed that EVEV-seroposi-
tive dogs were spatially dispersed throughout the state
(Figure 1). The seropositive dogs resided in major human
population centers (Miami, Ocala, and Tallahassee), areas
from which more samples were collected because this
study focused on domestic canines. Unexpectedly, we
observed that EVEV-seropositive dogs lived farther north
than the recorded EVEV distribution, which only extends
to Indian River County (9). Owners of all 16 seropositive
dogs from northern and central Florida reported that their
pet had not traveled to counties in southern Florida, where
EVEV had been previously recorded. The reported Cx.
(Mel.) cedecei distribution extends only as far north as
Brevard County (9). The 633 serum samples were grouped
on the basis of counties in which EVEV activity or Cx.
cedecei have been previously recorded (Figure 1). A total
of 286 samples were from dogs in counties in which the
mosquito vector or EVEV has been recorded (“recorded”),
and 347 samples were from dogs in counties where neither
the vector nor virus has been recorded (“not recorded”).
No significant differences in seroprevalence were found
between the recorded group (9/277) and the not-recorded
group (18/329) (χ2 = 1.59, df = 1, p>0.05).
Environmental Characteristics of Seropositive-
Dog Residences
Figure 2 shows residence locations of EVEV-seroposi-
tive dogs overlaid on Florida National Land Cover Data
(NLCD) types. Satellite imagery showed that EVEV-
seropositive dogs were no more likely to live in rural,
forested, or agricultural areas favored by Cx. (Mel.) cede-
cei than seronegative animals (data not shown). Most
(16/26) EVEV-seropositive dogs lived in suburban, urban,
or residential environments, a proportion no different from
the proportion found for 26 EVEV-seronegative dogs
(16/26) chosen by random selection. NLCD data are gen-
erally used for broad-scale analysis and do not classify
microhabitats. These observations indicate that microhabi-
tats may play a more important role as a predictor of
EVEV canine seropositivity than NLCD classifications. In
addition to habitat type, no association was found between
the location of EVEV-seropositive dogs and average annu-
al precipitation, average annual or minimum temperature,
and proximity to bodies of water (data not shown).
Discussion
The objective of this study was to determine the distri-
bution of EVEV activity in Florida on the basis of sero-
prevalence in pet dogs that live in close proximity to
humans. Although virus isolation from mosquitoes or ver-
tebrates would be the most definitive measure of virus
activity, attempting to isolate EVEV throughout Florida is
logistically challenging and not currently conducted by the
state health department. To more precisely determine loca-
tions in which canine EVEV infection occurs, seronegative
dogs could be housed in specific habitat types in which
mosquitoes test positive for EVEV. Other studies that
would be useful to corroborate our findings include sero-
surveys in rodents that serve as EVEV reservoir hosts and
that have very limited dispersal ranges. Cattle with known
histories have also proven useful as VEEV sentinels (23).
EVEV Seropositivity in Northern Florida
Detection of EVEVantibody in dogs living in north and
central Florida, without history of travel to south Florida,
where EVEV was previously known to be endemic, indi-
cates that EVEV distribution probably extends farther
north than previously reported. Possible explanations for
this unexpected finding include the following: 1) Dogs
residing in the northern parts of Florida became infected
during their trip to the veterinary clinic in Gainesville (a
clinic visit was common to the history of all of these dogs).
We believe that this explanation is highly unlikely because
the clinics are indoors and probably are not infested by
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Figure 2. Residence locations of Everglades virus–seropositive
and –seronegative dogs in Florida and landcover habitat types
obtained from the National Land Cover Database.many mosquitoes and because even if a dog were bitten by
an infected mosquito in or on the way into the clinic, dogs
do not seroconvert until several days after infection.
2) Cross-reactive antibodies generated by other alpha-
viruses endemic to northern Florida were not responsible
for EVEV neutralizing antibodies. Overall, 4% of the dog
sera we tested contained neutralizing EVEV antibodies, a
rate similar to the seroprevalence for the major human
pathogenic arboviruses (EVEV, EEEV, Saint Louis
encephalitis virus, Western equine encephalitis virus) in
Florida detected in >2,500 sera from wildlife in 38 of the
state’s 67 counties from 1965 to 1974 (24). However,
alphavirus- neutralizing antibodies generally do not cross-
react, and none of the EVEV-seropositive dogs had neu-
tralizing antibodies to EEEV or HJV, which indicates that
the dogs sampled were not infected with any known, relat-
ed, sympatric alphaviruses.
When one considers that pet dogs live close to humans
and experience similar mosquito exposure as standard
arbovirus sentinels that are housed outdoors continuously in
cages (e.g., hamsters, chickens), these results suggest that
human infections with EVEV may also occur regularly in
many areas of Florida. Therefore, implementing procedures
to screen for EVEV in cases of febrile illness or encephali-
tis might result in recognition of undiagnosed disease.
Our geographic results may have been skewed by the
fact that two thirds of the dogs sampled were taken to the
referral hospital in Gainesville, potentially oversampling
dogs from this region of the state. Despite limitations
inherent to using serum samples that were not randomly
collected from all areas in Florida, detection of antibody in
north and central Florida suggests that the geographic dis-
tribution of EVEV is more extensive than previously
recorded and extends as far north as Tallahassee. EVEV
distribution could also extend outside of Florida, although
a serosurvey of raccoons in Georgia did not show EVEV
activity that far north (25).
Determinants of EVEV Distribution
These results raise a question: What determines the spa-
tial EVEV distribution in Florida? Several hypotheses war-
rant consideration. First, reservoir host susceptibility and
viremia limit the EVEV distribution. The distribution of
different cotton rat populations with respect to the known
EVEV distribution has not been delineated. However,
genetically distinct cotton rats from outside Florida are
highly permissive for EVEV viremia (26), which diminish-
es support for this theory. Second, mosquito species other
than Cx. (Mel.) cedecei serve as enzootic vectors in north-
ern Florida. The most abundant mammalophilic species in
regions of Florida in which EVEV was previously detect-
ed,  Aedes taeniorhynchus and  Cx. nigripalpus, are not
competent EVEV vectors in laboratory experiments (8).
Although marginally susceptible mosquito species have
been implicated as arbovirus vectors during outbreaks
when their large population sizes allow for efficient trans-
mission, the species implicated in those settings showed at
least some competence in laboratory susceptibility experi-
ments (27,28). By contrast, Ae. taeniorhynchus and  Cx.
nigripalpus were completely refractory to experimental
laboratory infection with EVEV (8). Also, enzootic viruses
in the VEEV complex, including EVEV, are typically high-
ly specific in their use of Culex. (Melanoconion) spp. as
primary vectors (29). Of the 7 vectors of enzootic VEE
complex viruses identified to date, all are members of the
Spissipes section in the Culex (Melanoconion) subgenus
(29). Nevertheless, other species, as well as populations of
Ae. taeniorhynchus and  Cx. nigripalpus from northern
Florida, should be evaluated in laboratory studies. Field
studies should also be conducted since EVEV circulating
in northern Florida could be capable of infecting Ae. tae-
niorhynchus or Cx. nigripalpus, unlike EVEV isolates and
mosquitoes from the Everglades that were used for labora-
tory vector competence studies. Ticks or other ectopara-
sites that are widely distributed in Florida could also serve
as vectors. Finally, one other possible explanation is that
the distribution of EVEV is limited by that of Cx. cedecei,
but the range of this vector extends beyond that previously
recorded or has expanded (or both). Because this species is
difficult to identify morphologically, systematic mosquito
sampling throughout the state is needed to address this
possibility.
Location mapping showed that EVEV-seropositive dogs
were not more likely than seronegative dogs to live in envi-
ronments typically inhabited by Cx. cedecei. These results
should be interpreted with caution because of limitations
inherent to using owner reports of pet travel histories. Cx.
cedecei has been trapped in hardwood hammocks in the
Everglades, mangrove swamps, and hardwood forests, but
little is known about its proclivity for disturbed or suburban
habitats. A closely related VEEV complex virus vector that
occurs in Central America, Cx. (Mel.) taeniopus (30), is
found in high abundance in habitats subject to heavy human
disturbance.  Cx. cedecei might also inhabit suburban or
urban areas, but it has not been identified in such environ-
ments because of limitations in identification practices.
Clinical Data
In spite of antibody detection in 4% of animals sam-
pled, clinical signs reported for all of the seropositive dogs
that were seen at the referral veterinary hospital in
Gainesville (detailed data not shown; most animals were
diagnosed with tumors or bacterial infections) were incon-
sistent with EVEV disease in humans (2) or laboratory
rodents (L.L. Coffey, unpub. data). These observations
indicate that EVEV was likely not the underlying cause for
Everglades Virus Antibody in Dogs, Florida
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 12, December 2006 1877the manifestations seen at these hospitals. Military sentry
dogs observed continuously during periods of natural
infection, verified by seroconversion, did not show signs
of VEE-like illness (13).
Despite the low EVEV antibody titers observed in
many of the EVEV-seropositive dogs, these results likely
represent real infections, especially given that no serum
samples from 61 dogs living in areas outside Florida test-
ed positive. Antibody titers in sentry dogs naturally infect-
ed with EVEV waned to low levels during a 1- to 2-year
period (13). The low titers reported here could result from
a long interval between infection and blood collection.
Alternatively, high antibody titers may never develop in
dogs naturally infected with EVEV. For example, 1 young
dog born in September 2003 and then sampled <1 year
later had a titer of only 40 (Table). The low EVEV anti-
body titers in naturally infected pet dogs in this study are
similar to those in sentry dogs (13) but are not as high as
titers in dogs experimentally injected with 1,000 suckling
mouse ICLD50 of EVEV (31) or VEE virus (14). Higher
neutralizing antibody titers might have developed in
experimentally infected dogs because the dose of virus
administered by intramuscular injection was greater than
the amount delivered by a feeding mosquito.
In summary, detection of antibody in dogs throughout
Florida suggests that EVEV extends as far north as
Tallahassee and has been circulating as recently as 2003.
Additional serosurveys involving more dogs, rodents, or
both throughout the state, in addition to attempts to isolate
EVEV from mosquitoes and vertebrates in regions where
seropositive dogs occur, will further define the geographic
distribution of EVEV. Enhanced vector surveillance could
better define the range of Cx. cedecei and may help to
explain the unexpected finding of EVEV activity in north-
ern Florida. Screening for EVEV in human patients may
also show wide spatial dispersion and a high rate of human
infection. EVEV may be a cause of febrile illness or
encephalitis in many areas of Florida and should be con-
sidered by physicians as a potential cause.
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